Cancer R&D 2024 has wrapped up successfully. We’re grateful for your interest and interaction with Alfa Cytology. We’re eager to continue providing our expertise in cancer drug development. Let’s look back on these memorable moments!

Neural Recombinant Proteins

Neural Recombinant Proteins

Recombinant mouse neurogenin 3 protein, His

CAT#: NRP-N011

Keywords: Neural recombinant proteins

Inquiry

Recombinant human Neurofascin protein, C-His

CAT#: NRP-N012

Keywords: Neural recombinant proteins

Inquiry

Recombinant human Ninjurin 1 protein, C-His

CAT#: NRP-N013

Keywords: Neural recombinant proteins

Inquiry

Recombinant human CD56 protein, C-His (HEK293)

CAT#: NRP-N014

Keywords: Neural recombinant proteins

Inquiry

Recombinant human NGF-β protein (Active, HEK293)

CAT#: NRP-N015

Keywords: Neural recombinant proteins

Inquiry

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

First
1
2
Last

Alfa Cytology provides its clients with one-stop solutions to accelerate therapeutic discovery and development of brain tumors.

By Disease

Craniopharyngioma

Schwannoma (neuroma)

Pituitary Tumors

Choroid Plexus Tumors

By Molecule Type

Small Molecule Drug

Therapeutic Antibody

Immune Cell Therapy

Oncolytic Virotherapy

Vaccine Development

Contact Us

Copyright © 2024 Alfa Cytology. All rights reserved.